X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2046) 2046
Publication (162) 162
Newsletter (44) 44
Book Review (25) 25
Book Chapter (19) 19
Book / eBook (4) 4
Dissertation (3) 3
Magazine Article (2) 2
Conference Proceeding (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1699) 1699
female (1246) 1246
index medicus (1082) 1082
middle aged (950) 950
oncology (902) 902
aged (808) 808
adult (725) 725
male (704) 704
cancer (699) 699
adenocarcinoma (673) 673
adenocarcinoma, mucinous - drug therapy (577) 577
prognosis (573) 573
chemotherapy (499) 499
tumors (425) 425
neoplasm staging (392) 392
antineoplastic combined chemotherapy protocols - therapeutic use (374) 374
adenocarcinoma, mucinous - pathology (347) 347
carcinoma (339) 339
ovarian neoplasms - drug therapy (338) 338
adenocarcinoma - drug therapy (336) 336
aged, 80 and over (326) 326
adenocarcinoma - pathology (322) 322
surgery (316) 316
research (307) 307
pancreatic cancer (288) 288
survival (284) 284
mutation (281) 281
treatment outcome (278) 278
metastasis (270) 270
pathology (262) 262
care and treatment (260) 260
ovarian neoplasms - pathology (256) 256
survival rate (255) 255
retrospective studies (250) 250
immunohistochemistry (246) 246
ovarian cancer (237) 237
animals (236) 236
adenocarcinoma, mucinous - surgery (229) 229
expression (223) 223
colorectal cancer (216) 216
diagnosis (215) 215
cancer therapies (200) 200
genetic aspects (200) 200
health aspects (196) 196
follow-up studies (195) 195
adenocarcinoma - genetics (193) 193
gene expression (192) 192
medical prognosis (187) 187
analysis (184) 184
medicine (182) 182
antineoplastic agents - therapeutic use (179) 179
research article (172) 172
combined modality therapy (167) 167
pancreatic neoplasms - pathology (166) 166
patients (166) 166
gastroenterology & hepatology (163) 163
adenocarcinoma, mucinous - mortality (156) 156
development and progression (156) 156
ductal adenocarcinoma (154) 154
chemotherapy, adjuvant (152) 152
lung cancer (151) 151
risk factors (151) 151
mice (150) 150
proteins (149) 149
adenocarcinoma - surgery (146) 146
disease-free survival (142) 142
multidisciplinary sciences (142) 142
adenocarcinoma, mucinous - secondary (138) 138
adenocarcinoma, clear cell - drug therapy (135) 135
obstetrics & gynecology (134) 134
gene expression regulation, neoplastic (127) 127
therapy (125) 125
pancreatic neoplasms - genetics (124) 124
studies (124) 124
adenocarcinoma - mortality (123) 123
drug therapy (123) 123
article (122) 122
biomarkers, tumor - metabolism (122) 122
cell line, tumor (122) 122
lymphatic metastasis (118) 118
ovarian neoplasms - mortality (118) 118
science (118) 118
fluorouracil - administration & dosage (117) 117
cystadenocarcinoma, serous - drug therapy (116) 116
biomarkers (114) 114
apoptosis (113) 113
lung neoplasms - pathology (112) 112
adenocarcinoma - metabolism (111) 111
survival analysis (111) 111
breast cancer (109) 109
kinases (109) 109
adenocarcinoma, clear cell - pathology (105) 105
colorectal neoplasms - pathology (104) 104
ovarian neoplasms - surgery (104) 104
stomach neoplasms - pathology (104) 104
stomach neoplasms - drug therapy (103) 103
lung neoplasms - genetics (102) 102
medicine, research & experimental (102) 102
biomarkers, tumor - genetics (101) 101
neoplasm invasiveness (101) 101
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1921) 1921
Japanese (74) 74
Chinese (37) 37
German (21) 21
Russian (18) 18
French (17) 17
Italian (10) 10
Spanish (7) 7
Polish (3) 3
Hungarian (2) 2
Turkish (2) 2
Ukrainian (2) 2
Croatian (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 06/2014, Volume 20, Issue 12, pp. 3087 - 3093
Journal Article
The Journal of Pathology, ISSN 0022-3417, 01/2013, Volume 229, Issue 1, pp. 111 - 120
Mucinous ovarian carcinomas (MCs) typically do not respond to current conventional therapy. We have previously demonstrated amplification of HER2 in 6 of 33... 
mutation | KRAS | HER2 | heterogeneity | Ovarian cancer | GYNECOLOGIC-ONCOLOGY-GROUP | IMMUNOHISTOCHEMICAL EXPRESSION | ANTI-EGFR THERAPY | PATHOLOGY | GROWTH-FACTOR RECEPTOR | ADVANCED-STAGE | ONCOLOGY | GASTRIC-CANCER | COLORECTAL-CANCER | ANTI-HER2 ANTIBODY | PREDICTIVE FACTORS | PATHOLOGISTS GUIDELINE RECOMMENDATIONS | Immunohistochemistry | Multivariate Analysis | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Receptor, ErbB-2 - genetics | United States | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - mortality | Molecular Targeted Therapy | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Time Factors | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Adenocarcinoma, Mucinous - chemistry | Adenocarcinoma, Mucinous - drug therapy | Ovarian Neoplasms - drug therapy | Genetic Predisposition to Disease | Ovarian Neoplasms - chemistry | Risk Assessment | Biomarkers, Tumor - analysis | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | In Situ Hybridization, Fluorescence | Proto-Oncogene Proteins - genetics | Adenocarcinoma, Mucinous - secondary | Disease Progression | Adenocarcinoma, Mucinous - mortality | Canada | Disease-Free Survival | Phenotype | Gene Amplification | Adolescent | Aged | Biomarkers, Tumor - genetics | Adenocarcinoma, Mucinous - genetics | Mutation | Receptor, ErbB-2 - analysis | Australia | Neoplasm Staging | Multivariate analysis | Tumors
Journal Article
Cancer, ISSN 0008-543X, 01/2016, Volume 122, Issue 2, pp. 213 - 221
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 07/2018, Volume 143, Issue 2, pp. 355 - 367
Mucinous type of epithelial ovarian cancer (MuOC) is a unique subtype with a poor survival outcome in recurrent and advanced stages. The role of type‐specific... 
proteasome inhibitors | mucinous ovarian carcinoma | methylation profiles | functional genetic interactions | PSMB8 | STEM-CELLS | DNA METHYLATION | RAS | SELF-RENEWAL | LARGE GENE LISTS | CANCER | TUMORS | BIOMARKERS | ONCOLOGY | SIGNALING PATHWAY | BORDERLINE | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Cystadenoma, Mucinous - metabolism | Ovarian Neoplasms - genetics | DNA Methylation | Carcinoma, Ovarian Epithelial - drug therapy | Epigenomics - methods | Female | Ovarian Neoplasms - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Adenocarcinoma, Mucinous - drug therapy | Ovarian Neoplasms - drug therapy | Gastrointestinal Neoplasms - metabolism | Carcinoma, Ovarian Epithelial - genetics | Cell Survival - drug effects | Cystadenoma, Mucinous - genetics | Proteasome Inhibitors - pharmacology | Carcinoma, Ovarian Epithelial - metabolism | Cystadenoma, Mucinous - drug therapy | Proteasome Endopeptidase Complex - genetics | Adenocarcinoma, Mucinous - metabolism | Cell Line, Tumor | Cell Proliferation - drug effects | Adenocarcinoma, Mucinous - genetics | Proteasome Endopeptidase Complex - metabolism | Oligopeptides - pharmacology | Cluster Analysis | Immunohistochemistry | Cellular proteins | Corticosteroids | Carcinoma | Proteolysis | Analysis | Colorectal cancer | Methylation | Ovarian cancer | Cancer | Adenocarcinoma | Cluster analysis | Ovarian carcinoma | Glucocorticoids | Genes | Staining | Nuclei (nuclear physics) | Adenoma | Nuclei | Proteins | Network analysis | Genetic analysis | DNA methylation | Uncertainty analysis | Deoxyribonucleic acid--DNA | Stomach | Clustering | Proteasome inhibitors | Inhibitors | Transport | Tumors | Cancer Genetics and Epigenetics
Journal Article
International Journal of Cancer, ISSN 0020-7136, 2015, Volume 136, Issue 2, pp. 333 - 339
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 12, pp. 1554 - 1561
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2007, Volume 108, Issue 3, pp. 619 - 626
Abstract Objectives. Folate receptor α (FRα) is a folate-binding protein overexpressed on ovarian and several other epithelial malignancies that can be used as... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Folate receptor | Ovarian cancer | 5-METHYLTETRAHYDROFOLATE | VIVO | ovarian cancer | BINDING-PROTEIN | folate receptor | CELL-GROWTH | OBSTETRICS & GYNECOLOGY | BREAST-CANCER | IN-VITRO | ONCOLOGY | TISSUES | IMAGING AGENTS | EXPRESSION | CARCINOMA | Immunohistochemistry | Folate Receptors, GPI-Anchored | Adenocarcinoma, Mucinous - pathology | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Cystadenocarcinoma, Serous - metabolism | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Cystadenocarcinoma, Serous - genetics | Ovarian Neoplasms - mortality | Cystadenocarcinoma, Serous - pathology | Neoplasm Recurrence, Local - mortality | Cystadenocarcinoma, Serous - drug therapy | Carcinoma, Endometrioid - metabolism | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasm Metastasis | Female | Ovarian Neoplasms - metabolism | Retrospective Studies | Adenocarcinoma, Mucinous - drug therapy | Ovarian Neoplasms - drug therapy | Carcinoma, Endometrioid - genetics | Neoplasm Recurrence, Local - metabolism | Adenocarcinoma, Clear Cell - metabolism | Medical Records | Receptors, Cell Surface - metabolism | Minnesota | Carcinoma, Endometrioid - drug therapy | Adenocarcinoma, Mucinous - mortality | Carrier Proteins - genetics | Disease-Free Survival | Carrier Proteins - metabolism | Carcinoma, Endometrioid - mortality | Adenocarcinoma, Mucinous - metabolism | Survival Analysis | Cystadenocarcinoma, Serous - mortality | Neoplasm Recurrence, Local - genetics | Adenocarcinoma, Clear Cell - pathology | Adenocarcinoma, Mucinous - genetics | Adenocarcinoma, Clear Cell - genetics | Carcinoma, Endometrioid - pathology | Adenocarcinoma, Clear Cell - drug therapy | Receptors, Cell Surface - genetics | Folic acid
Journal Article